Dexamethasone, First Steroid to Fight COVID-19 Cases

According to a Research Team press release, an inexpensive, popular steroid boosts survival levels for COVID-19 patients on ventilators. According to the team, the drug, called dexamethasone, lowered deaths by one third in patients on respirators, and by one-fifth in patients requiring oxygen therapy. It didn’t help those patients who could breathe alone. 

Steroids such as blunt infection of dexamethasone within the body. Researchers believe that some individuals with high cases of COVID-19 have hazardously high levels of inflammation as part of an overactive immune response to the virus and that calming that down with an anti-inflammatory like dexamethasone could help ease their symptoms. 

This is also why people should not take this drug to try to prevent COVID-19: it affects the immune system and may make it more difficult to fight off the virus. Scientists say the treatment works when someone’s illness is serious enough to cause infection more harmful than the virus itself. 

Dexamethasone is the first drug that has been shown to improve survival in COVID-19, “said in a statement Peter Horby, professor of emerging infectious diseases at the University of Oxford and a lead investigator on the trial. In those patients who are ill enough to need oxygen therapy, the survival advantage is obvious and massive. 


PTA Taxes Portal

Find PTA Taxes on All Phones on a Single Page using the PhoneWorld PTA Taxes Portal

Explore NowFollow us on Google News!

Nayab Khan

Nayab Khan is a freelance tech-writer whose specialty is absorbing the key data and articulating the most important points. She helps IT based organizations communicate their message clearly across multiple channels.

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Get Alerts!

PhoneWorld Logo

Join the groups below to get the latest updates!

💼PTA Tax Updates
💬WhatsApp Channel